NCT04494048 Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry
| NCT ID | NCT04494048 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Weill Medical College of Cornell University |
| Condition | Obesity |
| Study Type | OBSERVATIONAL |
| Enrollment | 9,999 participants |
| Start Date | 2016-04-05 |
| Primary Completion | 2035-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 9,999 participants in total. It began in 2016-04-05 with a primary completion date of 2035-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this registry study is to collect data through medical chart review and in patient visits on the efficacy and safety of various Endoscopic Bariatric therapies (EBTs). This is a retrospective and prospective, observational, medical chart review study for at least 6 standard of care visits up to 1 years after a subject consents for study participation.
Eligibility Criteria
Inclusion Criteria: * Any patient who is considering undergoing EBT for weight loss within 6 months, or has undergone clinically indicated EBT for weight loss within the past 6 months * Above or equal to 18 years of age. Exclusion Criteria: * Any patient who has not undergone or will undergo EBT for weight loss * Below 18 years of age.
Contact & Investigator
Reem Z Sharaiha, MD
PRINCIPAL INVESTIGATOR
Weill Medical College of Cornell University
Frequently Asked Questions
Who can join the NCT04494048 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 89 Years, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04494048 currently recruiting?
Yes, NCT04494048 is actively recruiting participants. Contact the research team at rzs9001@med.cornell.edu for enrollment information.
Where is the NCT04494048 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT04494048 clinical trial?
NCT04494048 is sponsored by Weill Medical College of Cornell University. The principal investigator is Reem Z Sharaiha, MD at Weill Medical College of Cornell University. The trial plans to enroll 9,999 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.